Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
InterAACT: Cisplatin + 5-FU vs Carboplatin + Paclitaxel in Advanced Anal Cancer
NCT02560298Phase 2Unknown
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Start
- Aug 2016
- Primary completion
- Aug 2021
- Modality
- Nanoparticles, DNA Intercalators/Alkylators, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132), fluorouracil, carboplatin, Paclitaxel Micelles for Injection in anal cancer, sponsored by ECOG-ACRIN Cancer Research Group. Status: unknown.
02
Drugs
Cisplatin micelle injection (HA132)fluorouracilcarboplatinPaclitaxel Micelles for Injection
03
Conditions
anal cancer
Beyond the preview
Go deeper on NCT02560298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02560298.